- Home
- BLIV vs ALGS Comparison
BLIV vs ALGS Comparison
Compare BLIV & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- ALGS
- Stock Information
- Founded
- BLIV 2014
- ALGS 2018
- Country
- BLIV Singapore
- ALGS United States
- Employees
- BLIV N/A
- ALGS N/A
- Industry
- BLIV
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- BLIV
- ALGS Health Care
- Exchange
- BLIV NYSE
- ALGS Nasdaq
- Market Cap
- BLIV 39.8M
- ALGS 36.0M
- IPO Year
- BLIV 2025
- ALGS 2020
- Fundamental
- Price
- BLIV $4.33
- ALGS $5.29
- Analyst Decision
- BLIV
- ALGS Strong Buy
- Analyst Count
- BLIV 0
- ALGS 1
- Target Price
- BLIV N/A
- ALGS $70.00
- AVG Volume (30 Days)
- BLIV 154.8K
- ALGS 163.7K
- Earning Date
- BLIV 01-01-0001
- ALGS 05-06-2025
- Dividend Yield
- BLIV N/A
- ALGS N/A
- EPS Growth
- BLIV N/A
- ALGS N/A
- EPS
- BLIV N/A
- ALGS N/A
- Revenue
- BLIV $1,355,200.00
- ALGS $3,270,000.00
- Revenue This Year
- BLIV N/A
- ALGS N/A
- Revenue Next Year
- BLIV N/A
- ALGS N/A
- P/E Ratio
- BLIV N/A
- ALGS N/A
- Revenue Growth
- BLIV N/A
- ALGS N/A
- 52 Week Low
- BLIV $2.69
- ALGS $3.76
- 52 Week High
- BLIV $6.40
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- ALGS 43.20
- Support Level
- BLIV N/A
- ALGS $5.47
- Resistance Level
- BLIV N/A
- ALGS $6.12
- Average True Range (ATR)
- BLIV 0.00
- ALGS 0.60
- MACD
- BLIV 0.00
- ALGS 0.12
- Stochastic Oscillator
- BLIV 0.00
- ALGS 37.30
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.